quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:06:46·57d
SECFiling
Bloomin' Brands Inc. logo

SEC Form 10-K filed by Bloomin' Brands Inc.

BLMN· Bloomin' Brands Inc.
Consumer Discretionary
Full content unavailable. See the original source below.
Original source

Companies

  • BLMN
    Bloomin' Brands Inc.
    Consumer Discretionary

Recent analyst ratings

  • Nov 7UpdateGoldman$7.00
  • Jan 27UpdateBofA Securities$13.00
  • Jan 7UpdateBarclays$13.00
  • Dec 5UpdateGoldman$13.00
  • Nov 11UpdateRaymond James-
  • Jan 23UpdateJP Morgan$26.00

Related

  • PR10d
    Bloomin' Brands, Inc. to Host Fiscal 2026 First Quarter Earnings Conference Call at 8:00 AM EDT on May 6, 2026
  • PR10d
    Legacy 4-H Club Expresses Gratitude for Strong Community Support of Annual Lucas Founders Day Silent Auction
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by Bloomin' Brands Inc.
  • INSIDER42d
    Director Lal Rohit bought $56,900 worth of shares (10,000 units at $5.69), increasing direct ownership by 50% to 30,156 units (SEC Form 4)
  • INSIDER45d
    Director Kunkel Julie T. bought $6,460 worth of shares (1,000 units at $6.46) (SEC Form 4)
  • PR48d
    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
  • INSIDER49d
    EVP, Chief Commercial Officer Gonzalez Lissette R converted options into 4,861 shares and covered exercise/tax liability with 1,201 shares, increasing direct ownership by 9% to 46,483 units (SEC Form 4)
  • INSIDER49d
    SVP, Chief Accounting Officer Pace Philip J converted options into 3,240 shares and covered exercise/tax liability with 1,447 shares, increasing direct ownership by 4% to 45,408 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022